STADA Arzneimittel AG CFO Quits After Weak H1 Earnings

Bookmark and Share

Reuters -- German generic-drugs maker Stada Arzneimittel said its finance chief would leave immediately, without giving a reason, and also reported a 20 percent drop in first-half adjusted net income.

MORE ON THIS TOPIC